EichorEICHOR
Location: Pinehurst Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Pinehurst

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Phase 3 · FirstHealth of the Carolinas, Inc. · Daiichi Sankyo · NCT07022483A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Firsthealth of The Carolinas · Hoffmann-La Roche · NCT06793215Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Phase N/A · FirstHealth of the Carolinas-Moore Regional Hospital · PrECOG, LLC. · NCT06538038Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM
Phase 2 · FirstHealth of the Carolinas-Moore Regional Hospital · SWOG Cancer Research Network · NCT06769126Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · FirstHealth of the Carolinas-Moore Regional Hospital · NRG Oncology · NCT05174169Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastati
Phase 3 · FirstHealth of the Carolinas-Moore Regional Hospital · Alliance for Clinical Trials in Oncology · NCT06931340A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · FirstHealth of the Carolinas- Speciality Center /ID# 241279 · AbbVie · NCT04928846ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · FirstHealth of the Carolinas-Moore Regional Hospital · Alliance for Clinical Trials in Oncology · NCT06876714A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lu
Phase 2 · FirstHealth of the Carolinas · Johnson & Johnson Enterprise Innovation Inc. · NCT06667908Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · FirstHealth of the Carolinas-Moore Regional Hospital · Canadian Cancer Trials Group · NCT06592924An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel
Phase 2 · First Health of the Carolinas · NSABP Foundation Inc · NCT07058012Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-S
Phase 3 · FirstHealth of the Carolinas-Moore Regional Hospital · National Cancer Institute (NCI) · NCT06498635LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)
Phase 1/Phase 2 · Pinehurst Surgical Clinic · Locate Bio Pty Ltd · NCT06462729Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Dee
Phase 3 · Anthos Investigative Site 9950 · Anthos Therapeutics, Inc. · NCT05712200Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer
Phase 2 · FirstHealth Cancer Center · Teligene US · NCT05168566mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Neg
Phase 3 · FirstHealth of the Carolinas-Moore Regional Hospital · Alliance for Clinical Trials in Oncology · NCT05677490Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Phase 2/Phase 3 · FirstHealth Carolinas · Kartos Therapeutics, Inc. · NCT05797831Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · FirstHealth of the Carolinas-Moore Regional Hospital · National Cancer Institute (NCI) · NCT05987241Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-Hi
Phase 2 · Research Site · AstraZeneca · NCT06932263C-Brace Prospective Registry
Phase N/A · O&P of Pinehurst · Otto Bock Healthcare Products GmbH · NCT04640584Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had
Phase 2/Phase 3 · FirstHealth of the Carolinas-Moore Regional Hospital · SWOG Cancer Research Network · NCT06616584A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-
Phase 1 · FirstHealth of the Carolinas · Ankyra Therapeutics, Inc · NCT07027514Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
NA · FirstHealth of the Carolinas-Moore Regional Hospital · Alliance for Clinical Trials in Oncology · NCT07283939Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participa
Phase 3 · FirstHealth Cancer Center · Amgen · NCT06252649Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-sm
Phase 3 · FirstHealth Cancer Center · Daiichi Sankyo · NCT06899126Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Phase 3 · Research Site · AstraZeneca · NCT06307652The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Phase 3 · Pinehurst Medical Clinic, Inc. - East · Boehringer Ingelheim · NCT06872892A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Al
Phase 3 · FirstHealth of the Carolinas ( Site 6037) · Merck Sharp & Dohme LLC · NCT06952504Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · FirstHealth of the Carolinas-Moore Regional Hospital · National Cancer Institute (NCI) · NCT04267848
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.